Wealth Architects, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
Wealth Architects, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$327,787
-24.6%
12,1990.0%0.06%
-22.2%
Q2 2023$435,016
+12.7%
12,199
-19.7%
0.07%
+5.9%
Q1 2023$386,055
-37.4%
15,1990.0%0.07%
-41.9%
Q4 2022$616,471
+20.6%
15,199
-1.6%
0.12%
+9.3%
Q3 2022$511,000
-6.1%
15,4480.0%0.11%
+0.9%
Q2 2022$544,000
-23.5%
15,448
-0.0%
0.11%
-12.4%
Q1 2022$711,000
-30.6%
15,4530.0%0.12%
-32.8%
Q4 2021$1,025,000
+6.2%
15,4530.0%0.18%
-3.7%
Q3 2021$965,000
-24.6%
15,4530.0%0.19%
-25.5%
Q2 2021$1,280,000
+27.9%
15,453
+2.4%
0.25%
+15.7%
Q1 2021$1,001,000
-13.6%
15,0890.0%0.22%
-19.3%
Q4 2020$1,158,000
+78.2%
15,0890.0%0.27%
+52.8%
Q3 2020$650,000
-0.3%
15,0890.0%0.18%
-3.8%
Q2 2020$652,000
+50.2%
15,0890.0%0.18%
+21.2%
Q1 2020$434,000
-54.6%
15,0890.0%0.15%
-43.4%
Q4 2019$957,000
+126.2%
15,089
+0.6%
0.27%
+107.0%
Q3 2019$423,000
+59.6%
15,000
+50.0%
0.13%
+61.2%
Q2 2019$265,000
+44.0%
10,0000.0%0.08%
+40.4%
Q1 2019$184,000
+48.4%
10,0000.0%0.06%
+26.7%
Q4 2018$124,00010,0000.04%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders